Pfizer Strikes up to $6.05 Billion Licensing Deal for 3SBio's Cancer Drug Candidate
In This Article:
Pfizer (PFE) secured exclusive global rights, excluding China, to biopharmaceutical firm 3SBio's can
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.